With several new regimens nearing late-stage trials, a new generation of HIV antiretrovirals may soon be entering the marketplace.
HIV-positive donor, HIV-negative recipient; continuum of care after incarceration in U.S.; reduced bone mineral density among men with HIV under 50; discouraging anti-inflammatory findings for an antiplatelet agent.
As a last resort, doctors in South Africa have tranplanted part of an HIV-positive woman's liver into her HIV-negative child.
The benefits of pre-pregnancy HIV treatment initiation for mothers-to-be; HIV diagnoses rise among young U.S. MSM; cost effectiveness of PrEP for heterosexual women; methotrexate and arterial function.
More Than 30 Years Later, the UK Government Opens Inquiry Into Blood Contaminated With HIV and Hepatitis C
On Sept. 24, the first widespread inquiry into how thousands of people in the United Kingdom received contaminated blood in the 1970s and 1980s began with a preliminary hearing and a commemoration event dedicated to the victims.
How food insecurity feeds inflammation; racial disparities in HPV16 prevalence; how HIV meds affect pre-existing neurocognitive impairment; central nervous system inflammation in the setting of HIV treatment success.
NIH Clinical Trial to Track Outcomes of Kidney Transplantation From HIV-Positive Donors to HIV-Positive Recipients
The first large-scale clinical trial to study kidney transplantations between people with HIV has begun at clinical centers across the U.S.
Nearly a fifth of providers fail to do so, reports the CDC, paving the way for resistance.
Transplant programs are now studying the safety of conducting transplants from HCV-infected donors into HCV-uninfected recipients, then treating with HCV therapy.
Researchers found that people taking common combinations of HIV drugs had increases in weight and body mass index, and those who were relatively thin or older prior to starting therapy were most likely to gain weight.